France Drug Device Combination Products Market Size & Outlook

The drug device combination products market in France is expected to reach a projected revenue of US$ 10,837.7 million by 2030. A compound annual growth rate of 11.7% is expected of France drug device combination products market from 2024 to 2030.
Revenue, 2023 (US$M)
$4,996.2
Forecast, 2030 (US$M)
$10,837.7
CAGR, 2024 - 2030
11.7%
Report Coverage
France

France drug device combination products market, 2018-2030 (US$M)

France

Related Markets

France drug device combination products market highlights

  • The France drug device combination products market generated a revenue of USD 4,996.2 million in 2023 and is expected to reach USD 10,837.7 million by 2030.
  • The France market is expected to grow at a CAGR of 11.7% from 2024 to 2030.
  • In terms of segment, transdermal patches was the largest revenue generating product in 2023.
  • Drug Eluting Stents is the most lucrative product segment registering the fastest growth during the forecast period.


Drug device combination products market data book summary

Market revenue in 2023USD 4,996.2 million
Market revenue in 2030USD 10,837.7 million
Growth rate11.7% (CAGR from 2023 to 2030)
Largest segmentTransdermal patches
Fastest growing segmentDrug Eluting Stents
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhotodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters
Key market players worldwideAbbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates


Other key industry trends

  • In terms of revenue, France accounted for 3.6% of the global drug device combination products market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK drug device combination products market is projected to lead the regional market in terms of revenue in 2030.
  • Denmark is the fastest growing regional market in Europe and is projected to reach USD 6,320.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Drug Device Combination Products Market Companies

Name Profile # Employees HQ Website

France drug device combination products market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.


Transdermal patches was the largest segment with a revenue share of 22.77% in 2023. Horizon Databook has segmented the France drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.


The competition in France’s drug device combination products market is intense due to the growing geriatric population, which is at a high risk of developing ARDS, making it one of the EU’s fastest-aging countries and a favorable market for drug-device combination products. As per a French national hospital database (Programme de Médicalisation des Systèmes d’Information (PMSI)), in 2021, the crude incidence of ARDS was 6.7 cases per 100,000 in people aged 18 to 40 and 51.9 cases per 100,000 in people aged 68 to 76.

Hence, due to the growing demand for efficient solutions to deal with the shifting demographic dynamics and an increasing number of surgical procedures, this demographic evolution has resulted in intense rivalry in the drug device combination products market in France.

Reasons to subscribe to France drug device combination products market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France drug device combination products market databook

  • Our clientele includes a mix of drug device combination products market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into France drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France drug device combination products market size, by product, 2018-2030 (US$M)

France Drug Device Combination Products Market Outlook Share, 2023 & 2030 (US$M)

France drug device combination products market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more